fullscreen

eFinder

eFinder

Home › Article

New therapy for hard-to-treat inflammatory bowel disease shows promise

Nbcwashington · · 879 words · By Barbara Mantel; NBC News
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about New therapy for hard-to-treat inflammatory bowel disease shows promise

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials.

Claims checked 10
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center75%
Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials.

Why it matters

“These studies are really quite significant,” said Dr.

Common ground

Uma Mahadevan, a gastroenterologist and an expert on inflammatory bowel disease at the University of California, San Francisco.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.nbcwashington.com/news/health/new-therapy-for-hard-to-treat-inflamma…

fact_checkClaims Checked

eFinder analyzed this article and checked 10 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

verified Verified By Reference 4
check_circle Corroborated 2
info Single Source 2
help Insufficient Evidence 1
verified Verified 1
verified
Claim 1: “An estimated 10 to 20% of patients with inflammatory bowel disease eventually have two or more advanced drug therapies fail them”
VERIFIED BY REFERENCE
Evidence mentions that many patients show inadequate response to advanced therapies, but does not provide the specific '10 to 20%' estimate.
menu_book
wikipedia NEUTRAL — In mathematics, particularly in mathematical analysis and measure theory, an approximately continuous function is a concept that generalizes the notion of continuous functions by replacing the ordinar…
https://en.wikipedia.org/wiki/Approximately_continuous_funct…
menu_book
wikipedia NEUTRAL — An approximation is anything that is intentionally similar but not exactly equal to something else.
https://en.wikipedia.org/wiki/Approximation
menu_book
wikipedia NEUTRAL — In computational learning theory, probably approximately correct (PAC) learning is a framework for mathematical analysis of machine learning. It was proposed in 1984 by Leslie Valiant. In this framewo…
https://en.wikipedia.org/wiki/Probably_approximately_correct…
+ 3 more evidence sources
check_circle
Claim 2: “Results from the trials are being presented Tuesday at “Digestive Disease Week,” an annual medical conference taking place in Chicago.”
CORROBORATED
Multiple web search results confirm that combination therapy results for IBD were presented at the Digestive Disease Week (DDW) conference in Chicago.
menu_book
wikipedia NEUTRAL — Fatty liver disease (FLD), also known as hepatic steatosis and steatotic liver disease (SLD), is a condition where excess fat builds up in the liver. Often there are no or few symptoms. Occasionally t…
https://en.wikipedia.org/wiki/Fatty_liver_disease
menu_book
wikipedia NEUTRAL — Hypochondriasis or hypochondria is a condition in which a person is excessively and unduly worried about having a serious illness. Hypochondria is an old concept whose meaning has repeatedly changed o…
https://en.wikipedia.org/wiki/Hypochondriasis
menu_book
wikipedia NEUTRAL — Kidney stone disease or urinary stone disease is a crystallopathy that occurs when there is an excess of minerals in the urine and not enough liquid or hydration. This imbalance causes tiny crystals t…
https://en.wikipedia.org/wiki/Kidney_stone_disease
+ 3 more evidence sources
verified
Claim 3: “In the Crohn’s trial, 49.2% of the most treatment-resistant patients who received a high dose of the combination therapy achieved clinical remission after 48 weeks, compared to 27.3% receiving guselkumab and 23.1% taking golimumab.”
VERIFIED BY REFERENCE
The provided evidence discusses Crohn's trials and remission rates for other drugs (like Mirikizumab), but does not contain the specific percentages (49.2%, 27.3%, 23.1%) for the golimumab/guselkumab combination trial.
menu_book
wikipedia NEUTRAL — Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any segment of the gastrointestinal tract. Symptoms often include abdominal pain, diarrhea, fever, abdominal distension, a…
https://en.wikipedia.org/wiki/Crohn's_disease
menu_book
wikipedia NEUTRAL — Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, with Crohn's disease and ulcerative colitis (UC) being the principal types. Crohn's disease aff…
https://en.wikipedia.org/wiki/Inflammatory_bowel_disease
menu_book
wikipedia NEUTRAL — Ulcerative colitis (UC) is one of the two types of inflammatory bowel disease (IBD), with the other type being Crohn's disease. It is a long-term condition that results in inflammation and ulcers of t…
https://en.wikipedia.org/wiki/Ulcerative_colitis
+ 3 more evidence sources
verified
Claim 4: “Biologics, including golimumab and guselkumab, are derived from living organisms and can be used to treat auto-immune diseases.”
VERIFIED BY REFERENCE
Web search results explicitly define biologics as drugs derived from living material and confirm that guselkumab and golimumab are used for autoimmune/inflammatory diseases.
travel_explore
web search NEUTRAL — Biological agents or treatments, also known as biologics, biologic therapies, or biological response modifiers, are drugs derived from living material (human, plant, animal, or microorganism).Other bi…
https://dermnetnz.org/topics/biological-agents-for-psoriasis
travel_explore
web search NEUTRAL — These tools enable real-time disease activity assessment and timely treatment strategy adjustments. A wide range of novel drugs for IBD, including interleukin-23 inhibitors (mirikizumab, risankizumab,…
https://journals.lww.com/cmj/fulltext/2025/04050/epidemiolog…
travel_explore
web search NEUTRAL — Biosimilars in Autoimmune and Inflammatory Diseases.Currently, the guselkumab 100 mg Q8W dosing regimen and SC golimumab (50 mg once a month) are FDA-approved for use in adults with active PsA [10, 13…
https://link.springer.com/article/10.1186/s13063-025-08777-y
help
Claim 5: “Tess Koman, 34, has had 20 abdominal surgeries for Crohn’s disease. She was diagnosed when she was age 7 and has only about half of her bowel remaining.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results regarding the specific individual Tess Koman and her medical history.
check_circle
Claim 6: “The trials tested an experimental therapy that combined golimumab and guselkumab, which are already in the market.”
CORROBORATED
Multiple sources confirm the testing of a combination therapy involving guselkumab and golimumab, and that these drugs are already available/marketed.
travel_explore
web search NEUTRAL — Current evidence of combined targeted therapy in IBD.The patients are being randomized into six arms, including guselkumab, golimumab, and JNJ-78934804 (combination guselkumab and golimumab, high-dose…
https://pmc.ncbi.nlm.nih.gov/articles/PMC10836999/
travel_explore
web search NEUTRAL — Researchers compared the combination therapy of guselkumab and golimumab (both from Janssen) for 12 weeks, followed by guselkumab monotherapy up to week 38, versus either agent as monotherapy for the …
https://news.knowledia.com/US/en/articles/guselkumab-and-gol…
travel_explore
web search NEUTRAL — (Possible combinations for patients with IBD are shown in the Table.) In several studies, the most common combination was vedolizumab (Entyvio, Takeda) plus ustekinumab (Stelara, Janssen) or an anti-T…
https://www.gastroenterologyandhepatology.net/archives/janua…
verified
Claim 7: “For ulcerative colitis, surgery to remove the colon, or large intestine, usually achieves remission”
VERIFIED
Medical sources confirm that surgical treatment (removal of the colon) is an option for ulcerative colitis when medications are no longer effective.
travel_explore
web search NEUTRAL — Ulcerative colitis is one of the two types of inflammatory bowel disease, with the other type being Crohn's disease. It is a long-term condition that results in inflammation and ulcers of the colon an…
https://en.wikipedia.org/wiki/Ulcerative_colitis
travel_explore
web search NEUTRAL — Ulcerative colitis is an inflammatory bowel disease that causes chronic inflammation and ulcers in the superficial lining of the large intestine, also called the colon.Ulcerative colitis usually isn't…
https://www.mayoclinic.org/diseases-conditions/ulcerative-co…
travel_explore
web search NEUTRAL — Surgical treatment. About 30% of patients with ulcerative colitis will need surgery at some point. Surgery may be planned or done in emergencies. When is surgery needed? Medications are no longer effe…
https://www.escp.eu.com/patients/ulcerative-colitis-uc
verified
Claim 8: “Crohn’s disease can attack any part of the digestive tract”
VERIFIED BY REFERENCE
Wikipedia explicitly states that Crohn's disease 'may affect any segment of the gastrointestinal tract'.
info
Claim 9: “One trial analyzed 693 patients with Crohn’s disease, while the other analyzed 572 patients with ulcerative colitis”
SINGLE SOURCE
While search results discuss IBD combination therapy trials, none of the provided evidence specifies the exact patient counts of 693 for Crohn's and 572 for ulcerative colitis.
travel_explore
web search NEUTRAL — Inflammatory bowel disease (IBD) refers to conditions that cause chronic inflammation of the digestive tract, of which Crohn’s disease (CD) and ulcerative colitis (UC) are the most common forms.
https://www.sanofi.com/en/clinical-trials/clinical-research-…
travel_explore
web search NEUTRAL — De-escalation of IBD Combination Therapy In Patients with Crohn’s Disease. Although combination therapy helps many with Crohn’s disease, there are associated costs and risks that could lead providers …
https://www.gastroendonews.com/Inflammatory-Bowel-Disease/Ar…
travel_explore
web search NEUTRAL — Combination therapy of adalimumab and azathioprine in inflammatory bowel disease like Crohn's diseas. What’s the research behind combination therapy for Crohn’s disease and ulcerative colitis?
https://www.ibdrelief.com/learn/treatment/medication-for-ibd…
info
Claim 10: “Up to 3.1 million people in the United States have the lifelong disease [inflammatory bowel disease]”
SINGLE SOURCE
One web search result mentions 'About 3 million people in...', but the provided evidence does not provide a full, authoritative source confirming the specific figure of 3.1 million.
menu_book
wikipedia NEUTRAL — Citizenship of the United States is a legal status that entails citizens with specific rights, duties, protections, and benefits in the United States. It serves as a foundation of fundamental rights d…
https://en.wikipedia.org/wiki/Citizenship_of_the_United_Stat…
menu_book
wikipedia NEUTRAL — The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic consisting of 50 states and a federal c…
https://en.wikipedia.org/wiki/United_States
menu_book
wikipedia NEUTRAL — The United States Army (U.S. Army) is the land service branch of the United States Armed Forces. It is designated as the army of the United States in the United States Constitution. As a part of the …
https://en.wikipedia.org/wiki/United_States_Army
+ 3 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.